slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
237,541-237,570 of 319,975
01
Includes a screenshot of the Blockbuster online interface as it appeared in 2007.Blockbuster Video | Fixed Income Presentation Deck | 21 slides · Blockbuster
Conference presentation Investor relations Beat · Situation & Context1 hit
02
Blockbuster Video | Fixed Income Presentation Deck | 21 slidesBlockbuster Video | Fixed Income Presentation Deck | 21 slides · Blockbuster
Conference presentation Investor relations Beat · Situation & Context1 hit
03
Blockbuster Video | Fixed Income Presentation Deck | 21 slidesBlockbuster Video | Fixed Income Presentation Deck | 21 slides · Blockbuster
Conference presentation Investor relations Beat · Situation & Context1 hit
04
Blockbuster Video | Fixed Income Presentation Deck | 21 slidesBlockbuster Video | Fixed Income Presentation Deck | 21 slides · Blockbuster
Conference presentation Investor relations Beat · Situation & Context1 hit
05
Blockbuster Video | Fixed Income Presentation Deck | 21 slidesBlockbuster Video | Fixed Income Presentation Deck | 21 slides · Blockbuster
Conference presentation Investor relations Beat · Evidence & Proof1 hit
05
Project Plato branding present. Data tables compare standalone vs 45%, 55%, and 65% debt/cap scenarios.J.P.Morgan | Investment Banking Pitch Book | 5 slides · JPMorgan
Consulting deck Investment bank Beat · Evidence & Proof1 hit
01
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
02
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
03
The slide lists specific deal counts and revenue projections for validation and phase IV stages.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
04
Includes both executive management and board members.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Team1 hit
05
The slide features photos of the proprietary hardware and a line chart comparing 'Competitive' vs 'Two Step' assay performance.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
06
The slide illustrates a proprietary hardware/software stack.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a hub-and-spoke diagram to show data flow between healthcare stakeholders and a central informatics system.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
08
The slide highlights key performance metrics like sample size, assay time, and precision.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
09
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Solution1 hit
10
The slide illustrates a failure case (drug toxicity) to justify the value of the Theranos monitoring system.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
11
The chart shows a 'Second course (Drug dose reduced)' with three series: dose, drug level, and target.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
12
The chart shows a comparison between a 'first course' (uncontrolled) and a 'corrected' course where the drug level is managed.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
13
The chart illustrates a feedback loop: drug dose is reduced when toxicity markers exceed the alert level, successfully bringing toxicity down.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
14
The slide uses a bulleted list to break down market metrics including total market size, trial volume, and per-trial revenue projections.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Market Size1 hit
15
The slide explicitly notes that academic institutions are excluded from this TAM calculation.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · Market Size1 hit
16
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
17
The slide uses a bulleted list to highlight specific industry failures that the company intends to address.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
Theranos | Start Up Pitch Deck | 24 slidesTheranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
20
The slide specifies a split between existing and new investors.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Lists specific venture capital firms and individual investors.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses five distinct scientific charts to demonstrate technical parity or superiority of the Theranos system.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
23
This slide illustrates the core technical claim of the Theranos system's calibration and data processing workflow.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit
24
This is a closing/filler slide for a pitch deck template.Theranos | Start Up Pitch Deck | 24 slides · Theranos
Pitch deck Investor relations 1 hit